Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-22T22:06:17.252Z Has data issue: false hasContentIssue false
  • English
  • Français

Regional Infection Control Assessment of Antibiotic Resistance Knowledge and Practice

Published online by Cambridge University Press:  13 January 2015

Stephanie R. Black ,
Kingsley N. Weaver ,
Robert A. Weinstein ,
Mary K. Hayden ,
Michael Y. Lin ,
Mary Alice Lavin  and
Susan I. Gerber
Stephanie R. Black*
Affiliation:
Communicable Disease Program, Chicago Department of Public Health, Chicago, Illinois
Kingsley N. Weaver
Affiliation:
Communicable Disease Program, Chicago Department of Public Health, Chicago, Illinois
Robert A. Weinstein
Affiliation:
Division of Infectious Diseases, Cook County Health and Hospitals System, Chicago, Illinois Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois
Mary K. Hayden
Affiliation:
Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois
Michael Y. Lin
Affiliation:
Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois
Mary Alice Lavin
Affiliation:
Infection Prevention and Control, Rush University Medical Center, Chicago, Illinois (during the time of the survey; current affiliation is Illinois Department of Public Health, Office of Health Protection, Chicago, Illinois)
Susan I. Gerber
Affiliation:
Communicable Disease Program, Cook County Department of Public Health, Oak Forest, Illinois (during the time of the survey; current affiliation is Epidemiology Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia)
*
Address correspondence to Stephanie R. Black, MD, MSc, 2160 W. Ogden Ave., Chicago, IL 60612 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

OBJECTIVE

Multidrug-resistant organisms (MDROs) are an increasing burden among healthcare facilities. We assessed facility-level perceived importance of and responses to various MDROs.

DESIGN

A pilot survey to assess staffing, knowledge, and the perceived importance of and response to various multidrug resistant organisms (MDROs)

SETTING

Acute care and long-term healthcare facilities

METHODS

In 2012, a survey was distributed to infection preventionists at ~300 healthcare facilities. Pathogens assessed were Clostridium difficile, carbapenem-resistant Enterobacteriaceae (CRE), carbapenem-resistant Acinetobacter, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus, multidrug-resistant (defined as bacterial resistance to ≥3 antibiotic classes) Pseudomonas, and extended-spectrum β-lactamase-producing Escherichia coli.

RESULTS

A total of 74 unique facilities responded, including 44 skilled nursing facilities (SNFs) and 30 acute care facilities (ACFs). While ACFs consistently isolated patients with active infections or colonization due to these MDROs, SNFs had more variable responses. SNFs had more multi-occupancy rooms and reported less specialized training in infection control and prevention than did ACFs. Of all facilities with multi-occupancy rooms, 86% employed a cohorting practice for patients, compared with 50% of those without multi-occupancy rooms; 20% of ACFs and 7% of SNFs cohorted staff while caring for patients with the same MDRO. MRSA and C. difficile were identified as important pathogens in ACFs and SNFs, while CRE importance was unknown or was considered important in <50% of SNFs.

CONCLUSION

We identified stark differences in human resources, knowledge, policy, and practice between ACFs and SNFs. For regional control of emerging MDROs like CRE, there is an opportunity for public health officials to provide targeted education and interventions. Education campaigns must account for differences in audience resources and baseline knowledge.

Infect Control Hosp Epidemiol 2015;00(0): 1–6

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 36 , Issue 4 , April 2015 , pp. 381 - 386
Copyright
© 2015 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Hidron, AI, Edwards, JR, Patel, J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 2008;29:996–1011.CrossRefGoogle Scholar
2. Magill, SS, Edwards, JR, Stat, EM, et al. Multi-state point-prevalence survey of healthcare-associated infections. N Engl J Med 2014;370:1198–1208.Google Scholar
3. Bradford, PA, Bratu, S, Urban, C, et al. Emergence of carbapenem-resistant Klebsiella species possessing the Class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City. Clin Infect Dis 2004;39:55–60.CrossRefGoogle Scholar
4. Urban, C, Bradford, PA, Tuckman, M, et al. Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase β-lactamases associated with long term care facilities. Clin Infect Dis 2008;46:e127–e130.Google Scholar
5. Threat Report 2013. Centers for Disease Control and Prevention website. http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf. Published 2013. Accessed November 21, 2014.Google Scholar
6. Jarvis, WR. Infection control and changing health-care delivery systems. Emerg Infect Dis 2001;7:170–173.Google Scholar
7. Munoz-Price, LS. Carbapenem-resistant enterobacteriaceae, long-term acute care hospitals, and our distortions of reality. Infect Control Hosp Epidemiol 2013;34:835–837.Google Scholar
8. MRSA Screening and Reporting Act (210 ILCS 83/). IL General Assembly website. http://www.ilga.gov/legislation/ilcs/ilcs3.asp?ActID=2919&ChapterID=21. Published 2007. Accessed November 21, 2014.Google Scholar
9. 2012 AHQ Data Spreadsheet. IL Health Facilities and Services Review Board website. http://www.hfsrb.illinois.gov/HospProf_ABR.htm. Published 2013. Accessed November 21, 2014.Google Scholar
10. IDPH Skilled Nursing Facilities (Nursing Homes). State of Ilinois Data Portal. https://data.illinois.gov/Public-Health/IDPH-Skilled-Nursing-Facilities-Nursing-Homes-/jaeu-5c56.Published 2013. Accessed November 21, 2014.Google Scholar
11. Cohen, SH, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431–455.CrossRefGoogle Scholar
12. Won, SY, Munoz-Price, LS, Lolans, K, et al. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2011;53:532–540.CrossRefGoogle ScholarPubMed
13. Smith, DL, Dushoff, J, Perencevich, EN, Harris, AD, Levin, SA. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Soc Natl Acad Sci USA 2004;101:3709–3714.Google Scholar
14. Lee, BY, McGlone, SM, Wong, KF, et al. Modeling the spread of methicillin-resistant Staphylococcus aureus (MRSA) outbreaks throughout the Hospitals in Orange County, California. Infect Control Hosp Epidemiol 2011;32:562–572.Google Scholar
15. Moellering, RC Jr. NDM-1—a cause for worldwide concern. N Engl J Med 2010;363:2377–2379.Google Scholar
16. Schwaber, MJ, Lev, B, Israeli, A, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848–855.Google Scholar
17. 2012 CRE Toolkit-Guidance for Control of Carbapenem-resistant Enterobacteraceae (CRE). Centers for Disease Control and Prevention website. http://www.cdc.gov/hai/organisms/cre/cre-toolkit/. Published 2013. Accessed November 21, 2014.Google Scholar
18. Bradley, SF. Methicillin-resistant Staphylococcus aureus: long-term care concerns. Am J Med 1999;106:2S–10S.Google Scholar
19. Smith, PW, Bennett, G, Bradley, S, et al. SHEA/APIC guideline: infection prevention and control in the long-term care facility. Am J Infect Control 2008;36:504–535.Google Scholar
20. Nursing Home Care Act (210 ILCS 45/2-213). Illinois General Assembly website. http://www.ilga.gov/legislation/ilcs/ilcs5.asp?ActID=1225&ChapterID=21. Published 2012. Accessed November 21, 2014.Google Scholar
21. Detect and Protect Against Antibiotic Resistance. Centers for Disease Control and Prevention website. http://www.cdc.gov/drugresistance/detect-and-protect/. Published 2014. Accessed November 21, 2014.Google Scholar
22. XDRO registry. XDRO registry website. https://www.xdro.org/index.html. Published 2013. Accessed November 21, 2014.Google Scholar